| Literature DB >> 31440671 |
Takashi Hirai1, Toshitaka Yoshii1, Hiroyuki Inose1, Tsuyoshi Yamada1, Masato Yuasa1, Shuta Ushio1, Satoru Egawa1, Keigo Hirai1, Atsushi Okawa1.
Abstract
INTRODUCTION: Patients treated with revision surgery after lumbar decompression with fusion typically have persistent low back pain and lower extremity numbness compared with patients treated with only primary surgery. No well-designed study has investigated the persistence and degree of pain after revision surgery following instrumented operation. The purpose of this study is to compare residual pain among patients who underwent reoperation and those who underwent only primary surgery for lumbar degenerative disorder using patient-based evaluation.Entities:
Keywords: adjacent segment disease; lumbar spinal fusion; pain; reoperation
Year: 2018 PMID: 31440671 PMCID: PMC6698521 DOI: 10.22603/ssrr.2017-0048
Source DB: PubMed Journal: Spine Surg Relat Res ISSN: 2432-261X
Reoperation Rate of Three Groups and Indications.
| 1F group | 2F group | ≥3F group | ||||||
|---|---|---|---|---|---|---|---|---|
| Age (years) | 69.6±9.6 | 70.4±8.8 | 66.4±15.0 | |||||
| Sex (Male, %) | 47.6% | 49.1% | 44.0% | |||||
| No. of patients treated with reoperation for late-phase complications | 5 (2.4%) | 6 (11.3%) | 11 (12.1%) | |||||
| Indication for reoperation and number of cases | ASD | 3 | ASD | 6 | ASD | 7 | ||
| PS loosening | 1 | Rod breaking | 2 | |||||
| Infection | 1 | PS loosening | 1 | |||||
| Infection | 1 | |||||||
| Revision surgery | Two-segment fusion | Decompression alone | 1 | Long fusion (Th-Pelvis) | 10 | |||
| Floating fusion | 3 | Screw replacement | 1 | Rod replacement | 1 | |||
| Non-floating fusion | 0 | Three-segment fusion | ||||||
| Long fusion (Th-Pelvis) | 1 | Floating fusion | 1 | |||||
| Irrigation | 1 | Non-floating fusion | 3 | |||||
Data are expressed as mean±standard deviation. 1F, 1-segment fusion; 2F, 2-segment fusion; ≥3F, ≥3-segment fusion; ASD: adjacent segment disease; PS, pedicle screw
Patient Demographics and Postoperative Outcomes after Propensity Score Matching.
| 1F group | 2F group | ≥3F group | |||||
|---|---|---|---|---|---|---|---|
| P | R | P | R | P | R | ||
| No. of patients | 4 | 4 | 6 | 6 | 11 | 11 | |
| Age (years) | 71.3±6.0 | 70.0±3.6 | 69.8±4.0 | 72.8±8.6 | 71.0±8.3 | 69.9±10.3 | |
| Estimated blood loss (mL) | 225±123.3 | 224.5±130.8 | 531.8±216.3 | 584.7±219.5 | 1256±867 | 1098±789 | |
| Duration of operation (min) | 220.0±21.1 | 210.0±20.5 | 265.5±54.4 | 280.2±36.5 | 397.2±154.2 | 410.5±149.2 | |
| Preoperative pain domain on the JOABPEQ | 28.3±37.6 | 50.0±44.3 | 19.0±21.9 | 47.7±43.0 | 68.0±37.4 | 57.0±36.9 | |
| Preoperative VAS | |||||||
| Low back pain | 61.7±13.5 | 62.5±28.8 | 71.0±27.6 | 59.5±19.2 | 59.5±17.5 | 57.0±36.9 | |
| Lower extremity pain | 76.7±29.1 | 60.0±24.5 | 79.3±17.9 | 67.3±19.8 | 48.0±34.7 | 51.2±42.9 | |
| Lower extremity numbness | 82.7±30.0 | 55.5±30.6 | 50.3±34.1 | 44.6±32.8 | 65.1±37.5 | 49.0±34.2 | |
| Postoperative Pain domain on the JOABPEQ | 100±0* | 21.5±24.8 | 71.0±0* | 31.2±36.8 | 78.5±27.3 | 66.7±28.0 | |
| Postoperative VAS | |||||||
| Low back pain | 3.7±13.5* | 55.0±40.1 | 28.3±6.7* | 48.6±27.7 | 18.3±25.5 | 23.3±25.5 | |
| Lower extremity pain | 0±0* | 74.3±17.1 | 27.7±14.7* | 57.6±30.9 | 11.0±14.3 | 37.7±37.4 | |
| Lower extremity numbness | 35.7±27.6 | 48.3±44.4 | 19.8±39.5 | 20.3±23.7 | 20.6±24.0 | 27.3±30.1 | |
Data are expressed as mean±standard deviation. *P<0.05. 1F, 1-segment fusion; 2F, 2-segment fusion; ≥3F, ≥3-segment fusion; JOABPEQ, ASD: adjacent segment disease; Japanese Orthopedic Association Back Pain Evaluation Questionnaire; PS, pedicle screw; VAS, visual analog scale
Figure 1.Patient-based pain scores in the 1F group. Low back pain on the JOABPEQ (A), VAS for low back pain (B), VAS for lower extremity numbness (C), and VAS for lower extremity pain (D).
Figure 2.Patient-based pain scores in the 2F group. Low back pain on the JOABPEQ (A), VAS for low back pain (B), VAS for lower extremity numbness (C), and VAS for lower extremity pain (D).
Figure 3.Patient-based pain scores in the ≥3F group. Low back pain on the JOABPEQ (A), VAS for low back pain (B), VAS for lower extremity numbness (C), and VAS for lower extremity pain (D).